• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Ami received CEP approval Gliclazide. With this approval, we`re one step closer

    PRESS RELEASE

    Intimation Under Regulation 30 For Approval Of Advance Authorisation.

    BSE INDIA

    Class 2 Medicines recall: Accord-UK Ltd, Gliclazide 40 mg Tablets PL 20075/0687

    GOVUK

    Indian Govt impose anti-dump duty on bulk drug import of Gliclazide from China

    TWOFOUR INSIGHT

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.